Qualified researchers are invited to submit investigator-sponsored research (ISR) and general research proposals for the 2024 Pfizer Global Medical Grants cycle.
Pfizer Global Medical Grants (GMG) is an industry-leading global grant and collaboration program. GMG supports over $100 million USD of externally-driven research, education, and improvement science initiatives annually via competitive grant programs and an open online portal.
Pfizer supports Investigator-Sponsored Research (ISR) projects that advance medical and scientific knowledge about our therapies.
An ISR is a type of grant that supports an independent research study where the investigator or organization is the sponsor of the study and where Pfizer provides financial and/or non-financial support for the development or refinement of specific and defined medical knowledge relating to a Pfizer asset. This global program is open to all researchers who are interested in conducting their own research. This grant type is used as support for pre-clinical and clinical studies (including interventional and non-interventional) that involve a Pfizer asset (e.g., commercial drug, investigational drug, pure compound).
Research areas for Pfizer Global Medical Grants 2024 support include, but are not limited to:
- Inflammation and Immunology Areas of Interest
- Vaccines and Antivirals
- Oncology
Application Process
To apply for the Pfizer Global Medical Grants 2024, click here
Deadline: January 14, 2024.
For more information on Pfizer Global Medical Grants 2024, visit the official site.
